Funded Tech Companies
Imvaq Therapeutics
Wondering who backed Imvaq Therapeutics? Hanne Capital and private investors put venture money into this biopharmaceutical company.
Company Overview
Company Name
Imvaq Therapeutics
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Undisclosed
New York, NY 10065
USA
New York, NY 10065
USA
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
Imvaq Therapeutics is an innovative cancer immunotherapy company founded by world-leading researchers at Memorial Sloan Kettering Cancer Center. The company is developing novel viral-based, armed immune-stimulating therapies to treat a variety of metastatic solid tumors including skin cancers, sarcoma, as well as hard-to-treat tumors such as triple-negative breast cancer.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
9/29/2020
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Choi
Company Investors
- Hanne Capital (John Jin)
Browse more funded tech companies:
Share this article
About Our Venture Capital Database
This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.
Additional Resources for Entrepreneurs